GITNUXSOFTWARE REVIEW
Biotechnology & PharmaceuticalsTop 10 Best Biologics Testing Services of 2026
Compare biologics testing services for biologics programs, with side-by-side coverage of Sartorius Stedim BioOutsource, Eurofins, and KBI Biopharma.
How we ranked these tools
Vendors set the topic, but our editors set the inclusion criteria and the evaluation framework before research starts.
AI search agents find sources, extract figures with provenance, and aggregate written reviews. They also transcribe video reviews and podcasts.
Framework: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page. This does not influence our reviews. Editorial policy
Sartorius Stedim BioOutsource is the best overall fit for programs that need outsourced, study-controlled biologics testing because it coordinates multiple assay types under a single technical plan with audit-ready documentation, whereas Almac Sciences suits teams wanting consistent, submission-ready potency, identity, and impurity workstreams since it aligns analytical streams into one study execution package.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
Sartorius Stedim BioOutsource
Study-managed testing packages that coordinate multiple assay types under a single technical plan.
Best for: Fits when programs need outsourced, study-controlled biologics testing with audit-ready documentation.
Eurofins BioPharma Product Testing
Editor pickGlobal biologics laboratory network coordinating regulated QC and development assays for multi-batch programs.
Best for: Fits when regulated biologics programs need dependable lab execution across QC and characterization evidence.
KBI Biopharma
Editor pickCoordinated delivery across potency, purity, impurity profiling, and safety testing under one study workflow.
Best for: Fits when regulated biologics programs need dependable lab execution across multiple assay types.
Comparison Table
Sartorius Stedim BioOutsource
enterprise_vendorBiologics testing laboratory specializing in biosimilar characterization and viral safety assays.
Study-managed testing packages that coordinate multiple assay types under a single technical plan.
Sartorius Stedim BioOutsource supports a wide set of biologics testing workflows that align with common development and quality needs, including characterization studies and specification-oriented testing packages. The delivery model is study-driven, with lab execution anchored to defined acceptance criteria and traceable documentation per study. Teams benefit when they need consistent execution across multiple assay types that often appear together in comparability and biosimilarity work.
A key tradeoff is that deeper automation and API-based integration depends on the specific engagement scope rather than being a self-serve software interface. This works well when biologics programs prioritize controlled study execution and audit-ready documentation over high-frequency data ingestion.
- +Broad assay coverage spanning characterization and specification testing
- +Study-managed execution with documentation organized for technical review
- +Strong fit for multi-assay packages used in comparability studies
- +Experienced lab execution supports cell-based and analytical assay workflows
- –API and automation surface is not consistently offered as a baseline
- –Onboarding can require more planning for study scope and sample logistics
Bioprocess development teams
Run comparability panels after process changes
Clear comparability evidence
Quality control leads
Confirm specifications for incoming lots
Faster release decisions
Show 1 more scenario
Regulatory strategy teams
Assemble documentation for submissions
Cleaner regulatory narratives
Results packages provide consistent structure for technical review.
Best for: Fits when programs need outsourced, study-controlled biologics testing with audit-ready documentation.
Eurofins BioPharma Product Testing
enterprise_vendorNetwork of GMP laboratories offering biologics safety testing, characterization, and release assays worldwide.
Global biologics laboratory network coordinating regulated QC and development assays for multi-batch programs.
Eurofins BioPharma Product Testing supports a broad set of biologics characterization and quality-control activities, including potency assay work, identity testing, and purity and impurity profiling modules used in release and development. It also runs viral safety and viral clearance study components that map to ICH-oriented expectations, plus baseline microbiology and contamination control tests used in batch qualification. For programs that require both analytical depth and controlled execution across multiple batches, the laboratory network and standardized study processes reduce handoff risk between study phases.
A key tradeoff is that integration depth varies by engagement structure, because data access, report formatting, and automation options depend on how the testing package is coordinated internally. Eurofins fits best when timelines depend on fixed study designs and when the delivery output needs to match regulated documentation expectations more than interactive analytics.
- +Broad biologics release and characterization coverage across core QC areas
- +Strong fit for multi-batch, stability-indicating and comparability-style programs
- +Viral safety oriented testing supports development and submission evidence needs
- +Global lab footprint helps maintain study throughput across regions
- –API and automation surface is not a primary focus for most engagements
- –Cross-site scheduling depends on method readiness and study planning discipline
Quality operations teams
Batch release testing coordination
Faster release evidence turnaround
Analytical development groups
Comparability and stability-indicating studies
Compelling comparability dataset
Show 1 more scenario
Program management
Viral safety testing plans
Regulatory-aligned study package
Executes viral safety and clearance components aligned to submission-ready study design expectations.
Best for: Fits when regulated biologics programs need dependable lab execution across QC and characterization evidence.
KBI Biopharma
enterprise_vendorCDMO providing integrated biologics development, manufacturing, and analytical testing services.
Coordinated delivery across potency, purity, impurity profiling, and safety testing under one study workflow.
KBI Biopharma supports biologics characterization workflows that map to both specification-style testing and broader study-driven programs, including potency, purity and impurity profiling, and microbiological testing. The provider also aligns execution with common safety and quality requirements such as mycoplasma, sterility, and endotoxin testing, which reduces fragmentation across vendors. For larger programs, the service model favors coordinated assay runs and consistent reporting packages across multiple methods. The typical engagement fits teams that already own the analytical strategy and need reliable lab execution and data packages.
A practical tradeoff is that turnaround and sequencing depend on lab scheduling and method availability, which can limit rapid iteration when assay designs change late. Another usage fit is comparability or biosimilarity programs that require repeatable assay performance across multiple timepoints, lots, or product states.
- +Wide coverage across potency, purity, impurities, and common sterility endpoints
- +Study-ready reporting for viral safety assessment and stability-related method execution
- +Consistent execution for multi-assay programs with aligned documentation
- +Method coordination helps reduce handoffs across related testing needs
- –Capacity-driven scheduling can slow changes to method order
- –Assay design iteration depth depends on what is provided at onboarding
- –Greater lab coordination effort required when scope expands after kickoff
- –Integration and API access are not central to the service delivery
CMC and QA program leads
Lot testing for release-style specifications
Fewer vendor handoffs
Analytical scientists
Comparability study assay execution
Repeatable assay datasets
Show 1 more scenario
Program managers
Viral safety and stability study support
Cohesive study documentation
KBI Biopharma packages safety and stability-indicating testing into study timelines with consolidated outputs.
Best for: Fits when regulated biologics programs need dependable lab execution across multiple assay types.
Almac Sciences
specialistContract development organization providing biologics analytical testing and characterization services.
Coordinated execution across multiple analytical streams under a single study plan for submission-ready reporting packages.
Almac Sciences delivers biologics testing support that centers on end-to-end laboratory execution for identity, potency, and impurity work. Teams benefit from managed study design and analytical execution for biologics characterization, including cell-based methods and chromatography-based analysis.
- +Method execution supports potency assay and purity testing in coordinated workflows
- +Study planning helps align identity testing and impurity profiling deliverables
- +Clear reporting structure supports regulatory-facing documentation needs
- +Cross-functional coordination reduces handoff churn across analytical teams
- –Workflow depth depends on project scope and requires tight requirements definition
- –Integration automation and API surface are not a primary part of service delivery
- –Less suitable for teams needing self-serve assay configuration tooling
- –Turnaround variability can increase when multiple matrix-specific methods are added
Best for: Fits when regulated biologics programs need consistent lab execution across potency, purity, and identity workstreams.
Charles River Laboratories
enterprise_vendorGlobal contract research organization providing preclinical and clinical laboratory services including comprehensive biologics testing.
CRO program management that combines potency execution with impurity and viral safety study coverage in one coordinated lab schedule.
Charles River Laboratories runs biologics testing programs that cover routine release testing and method development work across cell-based and analytical assays. Teams use Charles River’s labs for potency assay execution, impurity profiling, and stability-indicating study support with CRO-managed study plans and reporting packages.
- +Wide wet-lab coverage from potency work through impurity profiling
- +Study execution supports routine release and longer comparability timelines
- +Project coordination is built around CRO-managed assay runs and reporting
- +Cross-site continuity is easier for recurring assay programs
- –Governance and change control require disciplined input from sponsors
- –Method development lead times can extend when protocols need iterative tuning
- –Integration with internal lab systems is mostly mediated through deliverables
- –Assay scope breadth can mean less flexibility for bespoke niche endpoints
Best for: Fits when biopharma teams need CRO-managed biologics testing across multiple assay types for release and comparability.
Cambrex Bio Sciences
specialistContract development and manufacturing organization offering biologics analytical testing services.
Execution-centered delivery of potency and safety testing packages with controlled documentation for regulated study outputs.
Cambrex Bio Sciences provides outsourced biologics testing that centers on method execution across potency, purity, and safety workflows used during development and lifecycle studies. The service model emphasizes delivering study-ready lab results with clear traceability across analytical procedures for identity, impurity profiling, and microbial and viral safety testing.
- +Strength in end-to-end lab execution across development through lifecycle testing
- +Broad capability across cell-based potency and characterization style assays
- +Study package handling for regulated reporting formats and controlled documentation
- +Good fit for multi-assay projects with stable timelines and repeat batches
- –Limited evidence of a self-serve digital interface for run monitoring
- –Automation and API integration are not a primary part of the offering
- –Throughput quality depends on upfront study design and clear method specs
- –Some niche characterization requests may require subcontractor routing
Best for: Fits when teams need managed lab execution for multi-assay biologics characterization and safety studies.
Pacific BioLabs
specialistContract testing laboratory providing biologics characterization, bioassays, and preclinical safety testing.
Study execution packages that pair cell-based and analytical testing into one delivery stream for characterization and safety work.
Pacific BioLabs is a biologics testing provider focused on cell-based and analytical characterization work that supports biologics release and development studies. The service scope covers core identity, purity, and safety testing workflows plus assay development for potency and other characterization endpoints.
- +Broad coverage across identity, purity, and impurity profiling studies
- +Cell-based assay experience supports development-to-spec characterization
- +Method documentation supports repeatability across study batches
- +Study-style reporting supports downstream review and lifecycle handoffs
- –API and automation surface is not a primary channel for integration
- –Some specialized analytics depend on defined method availability
- –Turnaround responsiveness can vary by assay type and sample readiness
- –Governance controls like RBAC and audit logs are not a highlighted capability
Best for: Fits when mid-size teams need managed execution across multiple biologics testing endpoints.
BioAgilytix Labs
enterprise_vendorSpecialty bioanalytical CRO providing large-molecule bioanalysis and biomarker testing for biologics.
Central project coordination that ties cell-based assay planning to downstream analytical characterization packages.
BioAgilytix Labs delivers biologics testing and characterization work that centers on cell-based assay support plus analytical characterization workflows for biologics programs. The lab is geared toward identity, purity, and safety testing packages, with assay execution designed to fit study plans used for development and comparability.
- +Strong execution across cell-based assay and characterization workflows
- +Well-scoped biologics testing packages for identity, purity, and safety
- +Method documentation supports reproducible study execution
- +Practical turnaround coordination for multi-assay projects
- –Automation and API surface are not positioned for self-serve provisioning
- –Deep governance controls like RBAC and audit log are not emphasized
- –Data integration format options can depend on project coordination
- –Throughput scaling for many simultaneous studies may need scheduling lead time
Best for: Fits when development-stage biologics teams need structured multi-assay execution with hands-on study coordination.
Pace Analytical Life Sciences
specialistContract testing organization offering biologics method development, validation, and release testing.
Integrated study execution that couples potency bioassays with characterization panels for one decision package.
Pace Analytical Life Sciences delivers biologics characterization and analytical testing through contract bioassay development and lab-based characterization workflows. It is distinct for managing end-to-end assay execution that ties potency and identity methods to purification, impurity, and stability-related measurements in a single testing engagement.
- +Bioassay and characterization workstreams coordinated under one testing engagement
- +Method execution focus supports potency and identity alongside impurity and stability panels
- +Study-oriented delivery fits comparability and biosimilarity testing needs
- +Clear lab deliverables support internal review and cross-team decisioning
- –Digital integration details and API surface are not the primary capability signal
- –Complex workflow orchestration may depend on engagement-specific coordination
- –Automation depth for configuration and governance is not a standout differentiator
- –End-to-end data model standardization across studies is not emphasized
Best for: Fits when mid-size biologics teams need lab-led assay execution across potency, identity, and impurity testing.
Lonza Bioscience
enterprise_vendorContract development and manufacturing organization offering biologics analytical testing and release services.
Coordinated multi-module testing execution that keeps characterization and viral safety style requirements aligned across one program plan.
Lonza Bioscience supports biologics testing through an end-to-end lab services footprint that covers analytical development and routine release-style characterization across biologic modalities. The company is distinct for its scale in cell-based workflows and for bundling cross-discipline testing modules that reduce handoff between formulation, analytical, and safety assessments.
- +Broad assay coverage across characterization and safety testing modules
- +Experienced execution for cell-based and chromatography-linked workflows
- +Documented method delivery helps maintain consistency across study phases
- +Study management fits complex panels with multiple linked acceptance criteria
- –Integration requires early alignment on reference materials and specifications
- –Assay scheduling can extend timelines when many methods run in parallel
- –Some advanced characterization requests rely on method availability windows
- –Governance artifacts and study documentation depth can vary by program scope
Best for: Fits when large, specification-heavy biologics programs need coordinated characterization plus safety panel execution.
Conclusion
After evaluating 10 biologics testing, Sartorius Stedim BioOutsource stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
Frequently Asked Questions About Biologics Testing
How do Charles River and Lonza handle multi-assay study plans across release and comparability work?
Which providers are strongest for cell-based assay execution alongside chromatography-based characterization?
When does a company choose Eurofins BioPharma Product Testing over smaller labs like Pacific BioLabs?
How do Almac Sciences and Sartorius Stedim BioOutsource support regulated submission-ready documentation?
What onboarding steps reduce method transfer gaps between internal teams and outsourced labs like KBI Biopharma or Cambrex Bio Sciences?
Where does Lonza Bioscience typically fit better than BioAgilytix Labs for spec-heavy programs?
What tradeoffs appear when selecting a provider that is execution-centered versus one that offers consultative study coordination?
How do providers handle sample traceability and audit trail expectations for microbial and endotoxin testing?
Which providers cover broader assay coverage at the CRO program level rather than single-assay outsourcing?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
How to Choose the Right Biologics Testing
Options separate mainly by whether biologics testing outputs are traceable and reproducible across runs, not by the label on the workflow. Look for clear support for potency assay and identity testing with audit-ready reports.
Audit-ready test traceability
Why it matters
When biologics testing results must stand up during review, audit-ready test traceability prevents missing context between samples, runs, and calculations. It also helps you reproduce what you ran and why.
How to check
In a demo, load an example project and open one generated report end-to-end, from sample list to computed result. Ask how the system records method version, operator, raw inputs, and calculation steps in the report package.
Potency assay method controls
Why it matters
Potency assay method controls matter because small settings changes can shift outcomes. You need confidence that method parameters are locked, versioned, and reflected in the final outputs.
How to check
Choose a potency assay workflow example and check whether you can save a method template, then run with different versions. Ask to see where method version and key settings appear in the output files and report narrative.
Identity testing evidence handling
Why it matters
Identity testing is often used to confirm the right product and format, so the evidence trail must be consistent and complete. Better identity testing handling reduces ambiguity when results are close to cutoffs.
How to check
Run an identity testing example and inspect the evidence attachments linked to each sample result. Ask whether the tool records raw readouts, transformation steps, and how it displays acceptance logic.
Raw data import and mapping
Why it matters
Biologics testing often starts from instrument exports, and mapping determines whether the analysis stays faithful to the raw signals. This affects how quickly you can onboard new datasets and avoid transcription errors.
How to check
In the demo, upload a sample raw export (or a provided example) and follow how the tool maps columns/units into the workflow. Ask whether you can define a reusable import template and preview a “before analysis” mapping view.
Quality rules and flags
Why it matters
Quality rules and flags help you spot run problems before results spread into downstream decisions. For biologics testing, early detection around identity and potency reduces rework.
How to check
Ask the demo to run through a scenario with an intentionally flawed input and show what gets flagged. Check whether the flags point to the specific sample/run inputs that caused the issue and whether they appear in exports.
Red flags
- Identity testing outputs that lack raw evidence links or show only final numbers.
- Potency assay results that don’t clearly state which method version and settings were used.
- Import workflows that require manual column edits every time the file format changes.
Fit by situation
- If you regularly compile review packages, prioritize Audit-ready test traceability for every run.
- If your work depends on strict setup changes affecting outcomes, prioritize Potency assay method controls.
- If you need clear evidence for confirming the product, prioritize Identity testing evidence handling.
Funding and competing interests
This study was co-funded by several of the vendors assessed in it. No single vendor funded it. Funders could propose the market studied.
They had no role in selecting vendors, setting or weighting criteria, analysing data or drawing conclusions, and they received the same factual-accuracy check as every other vendor assessed.
Market definition, inclusion rules and criteria weights were fixed by an editor before research began and did not change afterwards. Editorial process →
- Service review · 2026 · Biotechnology PharmaceuticalsBiologics Analytical
- Service review · 2026 · Biotechnology PharmaceuticalsBiological Testing
- Service review · 2026 · Biotechnology PharmaceuticalsBiologics Contract Manufacturing
- Service review · 2026 · Biotechnology PharmaceuticalsBiologics Development
- Service review · 2026 · Biotechnology PharmaceuticalsBioanalytics
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→In this category
Biotechnology & Pharmaceuticals alternatives
See side-by-side comparisons of biotechnology & pharmaceuticals tools and pick the right one for your stack.
Compare biotechnology & pharmaceuticals tools→